ICTRP Search Portal

Main

Note: This record shows only 22 elements of the WHO Trial Registration Data Set. To view changes that have been made to the source record, or for additional information about this trial, click on the URL below to go to the source record in the primary register.

Register:	ClinicalTrials.gov
Last refreshed on:	28 February 2022
Main ID:	NCT03138473
Date of registration:	01/05/2017
Prospective Registration:	Yes
Primary sponsor:	Assiut University
Public title:	Impact of Residual Syntax Score and Syntax Revascularization Index on Outcomes of ACS Patients With Multi-Vessel Disease
Scientific title:	Impact of Residual Syntax Score and Syntax Revascularization Index on Outcomes of Acute Coronary Syndrome Patients With Multi-Vessel Disease
Date of first enrolment:	July 1, 2018
Target sample size:	149
Recruitment status:	Completed
URL:	https://clinicaltrials.gov/show/NCT03138473
Study type:	Observational
Study design:
Phase:

Countries of recruitment
Egypt

Contacts

Name:	Tarek A. Nagib, MD
Address:
Telephone:
Email:
Affiliation:	Department of Cardiology, Assiut University Faculty of Medicine

Name:	Khaled M. Elmaghraby, MD
Address:
Telephone:
Email:
Affiliation:	Department of Cardiology, Assiut University Faculty of Medicine

Name:	Salwa R. Dimitry, MD
Address:
Telephone:
Email:
Affiliation:	Department of Cardiology, Assiut University Faculty of Medicine

Key inclusion & exclusion criteria

Inclusion Criteria:

- All ACS (STEMI and NSTEACS) patients undergoing PCI in the setting of MVD.

Exclusion Criteria:

- Patients receiving fibrinolytic therapy.

- Patients with cardiogenic shock

- Post-CABG patients

- Patients with severe renal impairment

Age minimum: 18 Years
Age maximum: N/A
Gender: All

Health Condition(s) or Problem(s) studied

ACS - Acute Coronary Syndrome

Multi Vessel Coronary Artery Disease

NSTEMI - Non-ST Segment Elevation MI

STEMI - ST Elevation Myocardial Infarction

Intervention(s)

Diagnostic Test: SYNTAX Revascularization Index

Diagnostic Test: Residual SYNTAX Score

Primary Outcome(s)

In-hospital major adverse cardiac events (MACE) [Time Frame: 2 Years]

Secondary Outcome(s)

6 months- 1 year MACE, and its individual components. [Time Frame: 2 Years]

Major Bleeding [Time Frame: 2 Years]

The individual components of the primary end-point [Time Frame: 2 Years]

Acute kidney injury (AKI) [Time Frame: 2 Years]

Secondary ID(s)

17100078

Source(s) of Monetary Support

Please refer to primary and secondary sponsors

Secondary Sponsor(s)

Ethics review

Results

Results available:
Date Posted:
Date Completed:
URL:

Disclaimer: Trials posted on this search portal are not endorsed by WHO, but are provided as a service to our users. In no event shall the World Health Organization be liable for any damages arising from the use of the information linked to in this section. None of the information obtained through use of the search portal should in any way be used in clinical care without consulting a physician or licensed health professional. WHO is not responsible for the accuracy, completeness and/or use made of the content displayed for any trial record.